Equities

ImmuneOnco Biopharmaceuticals Shanghai Inc

ImmuneOnco Biopharmaceuticals Shanghai Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)5.01
  • Today's Change-0.31 / -5.83%
  • Shares traded11.21m
  • 1 Year change-82.11%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

ImmuneOnco Biopharmaceuticals Shanghai Inc is a China-based company mainly engaged in research and development of testing biotechnology. The Company's main businesses include the development of biotechnology for the systemic utilization of innate and adaptive immunity, and the development of next-generation tumor immunotherapies, which primarily focus on the adaptive immune system. The Company mainly operates its businesses in the domestic and overseas markets.

  • Revenue in HKD (TTM)--
  • Net income in HKD--
  • Incorporated2015
  • Employees145.00
  • Location
    ImmuneOnco Biopharmaceuticals Shanghai IncSHANGHAI ChinaCHN
  • Phone+86 2 138016387
  • Websitehttp://immuneonco.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Wuhan YZY Biopharma Co Ltd0.00-201.97m1.20bn114.00--21.92-----1.06-1.060.000.28150.00----0.00-83.99---230.17----------1.21-44.350.7078-------1.50------
Frontage Holdings Corp2.03bn47.53m1.24bn1.66k26.530.47353.670.6130.0230.0230.98921.290.470156.234.181,151,748.001.064.461.305.2828.5634.002.269.921.252.190.3110.003.7925.61-58.00-0.782640.43--
Hua Medicine119.89m-289.85m1.26bn172.00------10.48-0.2957-0.29570.1223-0.03720.07791.511.90677,343.20-18.84-25.61-23.63-28.8137.72---241.76-1,654.704.64--1.14--335.31---3.80--14.07--
Mabpharm Ltd166.86m-227.72m1.26bn347.00--9.92--7.54-0.0552-0.05520.04050.03070.1640.19373.26480,867.20-22.38-21.42-31.11-27.4986.91---136.47-486.400.6836-23.090.679--55.87--0.694---26.85--
Jacobio Pharmaceuticals Group Co Ltd25.51m-398.26m1.38bn298.00--1.39--54.14-0.513-0.5130.03291.260.016--2.4184,767.09-24.89-45.76-28.66-49.303.45---1,560.88-372.22----0.1794---33.66--3.43--19.18--
Immunotech Biopharm Ltd0.00-340.29m1.38bn211.00--15.51-----0.6613-0.66130.000.17340.00----0.00-35.21-37.42-55.75-45.48--------0.3638-2.440.6119-------5.25---8.46--
TOT Biopharm International Co Ltd1.07bn9.87m1.55bn551.00147.041.9422.121.440.01360.01361.481.030.68992.446.351,943,674.000.6356-20.010.8392-25.2172.0274.740.9212-68.531.632.980.3465--76.5481.8824.36--21.04--
Laekna Inc0.00-325.23m1.75bn92.00--2.35-----0.9127-0.91270.001.910.00----0.00-31.46---35.71--------------0.0856------52.81------
CARsgen Therapeutics Holdings Ltd6.98m-764.71m1.76bn477.00--1.08--252.30-1.37-1.370.01252.860.0027--0.30213,521.54-29.27---32.86--25.50---10,960.25--9.44--0.1246------16.19------
ImmuneOnco Biopharmaceuticls Shanghi Inc-100.00bn-100.00bn1.99bn145.00--3.01----------1.77----------------------------0.14---28.25--5.82------
CStone Pharmaceuticals502.41m-156.61m1.99bn164.00--3.87--3.96-0.1229-0.12290.39410.40080.28611.332.502,184,394.00-8.92-54.76-16.99-81.6870.73---31.17-301.621.45--0.4171---3.64--59.32--52.42--
Abbisko Cayman Ltd547.24m-17.83m2.12bn275.00--0.9214582.943.88-0.0302-0.03020.84263.350.2159----2,121,104.00-0.7034---0.733--100.00---3.26------0.0142------12.92------
Alphamab Oncology281.58m-237.30m2.44bn429.00--1.36--8.66-0.2465-0.24650.29251.860.11450.825613.94647,316.60-9.65-18.72-11.16-21.9479.33---84.27-415.554.42--0.167--31.12--35.35---13.12--
Biocytogen Pharmaceuticals Beijng Co Ltd881.03m-268.32m2.48bn1.04k--3.05--2.82-0.6737-0.67372.212.040.310923.645.35826,478.40-9.47---12.44--71.97---30.46--1.33-3.220.436--34.28--36.38------
Data as of Sep 20 2024. Currency figures normalised to ImmuneOnco Biopharmaceuticals Shanghai Inc's reporting currency: Hong Kong Dollar HKD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.